Clinical Trials Browser

Prostate Adenocarcinoma

NCT05087888 2026-04-15

MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation

Active not recruiting

9 enrolled

CNS

Brain Neoplasms

NCT04314401 2026-04-13

National Cancer Institute "Cancer Moonshot Biobank"

Active not recruiting

1,600 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicOther hematologic neoplasmPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Melanoma, Multiple Myeloma, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Clinical Trials

Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam

MRI and Blood Biomarkers for the Prediction of Neurocognitive Decline Following Brain Radiation

National Cancer Institute "Cancer Moonshot Biobank"

SHAPE-ENDO

Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm

Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer

Safety, Ultrasound Conspicuity, and Migration of Twinkling Markers in Patients With Locally Advanced Breast Cancer

Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma

Evaluation of 18F-TFB PET/CT Scan in Patients With Differentiated Thyroid Cancer

The i4i PRODICT® Study: Evaluation of the i4i PRODICT® Test in Different Ethnic Groups (The i4i PRODICT® Study).

Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer

Advanced Imaging Holistic Omics Biobank

LOTUS

Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation Therapy

GENPET

Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer

Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies

Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas

Multimodal Machine Learning Characterization of Solid Tumors

Assessing Brain Metabolism Using MRS With Deuterated Glucose

ReGIT

18F-fluciclovine PET/MRI Imaging for the Detection of Tumor Recurrence After Radiation Injury to the Brain

An Imaging Agent (Fluorodopa F 18) With Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Treatment Response in Patients With High-Grade Soft Tissue Sarcomas

S-C-PATHY

Cutting-edge IMAGING Technologies to Improve the SAFEty and the Sustainability of LUNG Cancer Screening and the Accuracy of Non-invasive Lung Nodules Characterization

Pilot Study of Pancreatic Cancer Screening

BARCODE1